日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical utility of pleural effusion supernatant cell-free DNA genotyping in previously treated patients with advanced non-small-cell lung cancer and disease progression: a multicenter retrospective study

胸腔积液上清液游离DNA基因分型在既往接受过治疗的晚期非小细胞肺癌进展患者中的临床应用价值：一项多中心回顾性研究

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.106023
Chang, S-C; Huang, C-Y; Lai, Y-C; Hsieh, M-S; Ho, C-C; Yang, C-Y; Shih, J-Y; Wu, S-G; Hu, P-W; Hsu, C-L; Chen, C-Y; Liao, W-Y
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

A novel BRCA mutation classification system reveals differential responses to PARP inhibition and prognostic outcomes in epithelial ovarian cancer: a multicenter study

一项多中心研究揭示了新型 BRCA 突变分类系统在卵巢上皮癌中对 PARP 抑制剂的不同反应和预后结果。

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106060
Liu, Q; Fan, Y; Huang, C; Wu, M; Jin, Y; Tao, L; Liu, Y; Song, J; Wang, S; Kong, W; Huang, X; Ha, C; Cui, Z; Zhao, D; Yang, X; Qiao, J; Zhang, Y; Li, Y; Guo, H
PARP
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

[A case of toxic shock syndrome secondary to severe bone marrow suppression induced by azathioprine in a patient with autoimmune hepatitis]

[一例自身免疫性肝炎患者因硫唑嘌呤引起严重骨髓抑制而继发中毒性休克综合征的病例报告]

期刊:Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
影响因子:
doi:10.3760/cma.j.cn501113-20250508-00180
Ren, Y; Kong, M; Huang, C Y; Bian, X Q; Liu, H X; Mou, D L; Chen, Y
免疫/内分泌
毒理研究
肝炎
自身免疫性肝炎
发表日期：2026
文献求助 收藏

A structured approach to promote equity in spatial accessibility to TB services during private sector engagement

在私营部门参与过程中，采取结构化方法促进结核病服务在空间可及性方面的公平性。

期刊:
影响因子:
doi:10.5588/ijtldopen.25.0599
Xiong, Y; Millones, A K; Huang, C-C; Zavala-Abriojo, E; Campos, H; Jimenez, J; Jordan, D R; Lecca, L; Jenkins, H E; Yuen, C M
发表日期：2026
文献求助 收藏

Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma

整合基因组学和精细的细胞起源亚型分析可区分弥漫性大B细胞淋巴瘤的亚型特异性治疗耐药和复发机制

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01326-5
Walker, Janek S; Wenzl, Kerstin; Novak, Joseph P; Stokes, Matthew E; Hopper, Melissa A; Dropik, Abigail R; Siminski, Miranda S; Bock, Allison M; Sarangi, Vivekananda; Ortiz, Maria; Stong, Nicholas; Huang, C Chris; Maurer, Matthew J; Link, Brian K; Ansell, Stephen M; Habermann, Thomas M; Witzig, Thomas E; King, Rebecca L; Nowakowski, Grzegorz; Cerhan, James R; Gandhi, Anita K; Novak, Anne J
B细胞
治疗耐药
淋巴瘤
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Tooth-on-a-chip to engineer early dental epithelial-mesenchymal interaction

利用芯片牙齿构建早期牙齿上皮-间质相互作用

期刊:Materials Today Bio
影响因子:10.2
doi:10.1016/j.mtbio.2025.102451
Huang, C; Sanaei, F; Zhang, W; Yelick, P C; Ji, W; Yang, F; Walboomers, X F
发表日期：2025
文献求助 收藏

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival

辅助性利博西尼联合非甾体类芳香化酶抑制剂治疗HR阳性/HER2阴性早期乳腺癌患者：NATALEE研究疗效结果的5年随访及更新的总生存期

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105858
Crown, J; Stroyakovskii, D; Yardley, D A; Huang, C-S; Fasching, P A; Bardia, A; Chia, S; Im, S-A; Martin, M; Xu, B; Barrios, C H; Untch, M; Moroose, R; Hurvitz, S A; Hortobagyi, G N; Slamon, D J; Visco, F; Spera, G; Zarate, J P; Halligan, D; Li, Z; Loi, S
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study

tiragolumab、atezolizumab 和化疗治疗早期或 PD-L1 阳性晚期三阴性乳腺癌的安全性和有效性：一项 Ib 期研究

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105869
Kuemmel, S; Jung, K H; Andrade, L; Assad-Suzuki, D; de la Cruz Merino, L; Freitas-Junior, R; Hegg, R; Huang, C-S; Martin, H; Schneeweiss, A; Dieterich, M; Nguyen Duc, A; Feng, Y; Meng, R; Swat, A; Seiller, A; Bermejo, B; Hamilton, E P
PD-L1
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Deep learning-based quantification of tumor-infiltrating lymphocytes as a prognostic indicator in nasopharyngeal carcinoma: multicohort findings.

基于深度学习的肿瘤浸润淋巴细胞定量分析作为鼻咽癌的预后指标：多队列研究结果

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105494
Lu T, Xie F, Hu Y, Zhan S, Zhong F, Chen J, Pan J, Gong X, Liu Z, Huang C, Xie C, Guo Q, Chua M L K, Li J
肿瘤
发表日期：2025
文献求助 收藏

Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance

与原发性治疗耐药相关的弥漫性大B细胞淋巴瘤的分子特征

期刊:Hematological Oncology
影响因子:3.9
doi:10.1002/hon.70006
Bock, Allison M; Wenzl, Kerstin; Novak, Joseph P; Stokes, Matthew E; Hopper, Melissa A; Krull, Jordan E; Dropik, Abigail R; Sarangi, Vivek; Ortiz, Maria; Stong, Nicholas; Huang, C Chris; Maurer, Matthew J; King, Rebecca L; Farooq, Umar; Wang, Yucai; Witzig, Thomas E; Ansell, Stephen M; Habermann, Thomas M; Cerhan, James R; Gandhi, Anita K; Nowakowski, Grzegorz; Novak, Anne J
B细胞
治疗耐药
淋巴瘤
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏